Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.01 USD | +3.22% | +1.44% | -26.09% |
05-30 | Baird Starts Privia Health Group With Outperform Rating, $23 Price Target | MT |
05-20 | Barclays Adjusts Price Target on Privia Health to $19 From $22, Maintains Equalweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.09% | 1.97B | |
+26.08% | 89.18B | |
-26.34% | 76.11B | |
+1.62% | 27.11B | |
-10.35% | 17.13B | |
-0.36% | 16.83B | |
+0.90% | 15.4B | |
+76.92% | 13.68B | |
+79.08% | 13.25B | |
-25.79% | 12.83B |
- Stock Market
- Equities
- PRVA Stock
- News Privia Health Group, Inc.
- UBS Adjusts Privia Health Group Price Target to $29 From $31, Maintains Buy Rating